J-Tan D SR Interactions
There are 472 drugs known to interact with J-Tan D SR (brompheniramine / phenylephrine), along with 8 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 35 are major, 434 are moderate, and 3 are minor.
- View all 472 medications that may interact with J-Tan D SR
- View J-Tan D SR alcohol/food interactions (1)
- View J-Tan D SR disease interactions (8)
Most frequently checked interactions
View interaction reports for J-Tan D SR (brompheniramine / phenylephrine) and the medicines listed below.
- Abilify (aripiprazole)
- Acetaminophen-odan (acetaminophen)
- Ambien CR (zolpidem)
- amitriptyline
- aspirin
- atenolol
- Augmentin (amoxicillin / clavulanate)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Belsomra (suvorexant)
- bupropion
- BuSpar (buspirone)
- Bystolic (nebivolol)
- citalopram
- clonazepam
- cyclobenzaprine
- Cymbalta (duloxetine)
- Deplin (l-methylfolate)
- Dexedrine (dextroamphetamine)
- diclofenac
- diflunisal
- doxepin
- Eskalith (lithium)
- Evening Primrose Oil (evening primrose)
- Excedrin Migraine (acetaminophen / aspirin / caffeine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flomax (tamsulosin)
- flumazenil
- fluoxetine
- fluvoxamine
- Ginkgo Biloba (ginkgo)
J-Tan D SR alcohol/food interactions
There is 1 alcohol/food interaction with J-Tan D SR (brompheniramine / phenylephrine).
J-Tan D SR disease interactions
There are 8 disease interactions with J-Tan D SR (brompheniramine / phenylephrine) which include:
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- BPH
- diabetes
- glaucoma
More about J-Tan D SR (brompheniramine / phenylephrine)
- Compare alternatives
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.